세계의 미만성 거대 B세포 림프종(DLBCL) 치료제 시장(2025-2029년)

The diffuse large b-cell lymphoma (DLBCL) therapeutics market is forecasted to grow by USD 2,457.1 mn during 2024-2029, accelerating at a CAGR of 8.2% during the forecast period. The report on the diffuse large b-cell lymphoma (DLBCL) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, increasing incidence of dlbcl, and increasing approval of therapeutics for patients with relapsed or refractory dlbcl.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's diffuse large b-cell lymphoma (DLBCL) therapeutics market is segmented as below:

By Product

• Small molecules
• Biologics

By Application

• Hospital pharmacy
• Retail pharmacy
• Online pharmacy
• Others

By Therapy

• Chemotherapy
• Immunotherapy
• Combination therapies
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the technological advances as one of the prime reasons driving the diffuse large b-cell lymphoma (DLBCL) therapeutics market growth during the next few years. Also, increasing patient support programs and strategic alliances will lead to sizable demand in the market.

The report on the diffuse large b-cell lymphoma (DLBCL) therapeutics market covers the following areas:

• Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market sizing
• Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market forecast
• Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diffuse large b-cell lymphoma (DLBCL) therapeutics market vendors that include AbbVie Inc., ADC Therapeutics SA, Amgen Inc., Bayer AG, BeiGene Ltd., Bristol Myers Squibb Co., Celltrion Healthcare Co. Ltd., Erytech Pharma SA, F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Seagen Inc., Spectrum Pharmaceuticals Inc., Swedish Orphan Biovitrum AB, Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the diffuse large b-cell lymphoma (DLBCL) therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Therapy
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2019 - 2023
  • Historic Market Size - Data Table on Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2019 - 2023 ($ million)
• 5.2 Product segment analysis 2019 - 2023
  • Historic Market Size - Product Segment 2019 - 2023 ($ million)
• 5.3 Application segment analysis 2019 - 2023
  • Historic Market Size - Application Segment 2019 - 2023 ($ million)
• 5.4 Therapy segment analysis 2019 - 2023
  • Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 The AI impact on Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

• 8.1 Market segments
  • Chart on Product - Market share 2024-2029 (%)
  • Data Table on Product - Market share 2024-2029 (%)
• 8.2 Comparison by Product
  • Chart on Comparison by Product
  • Data Table on Comparison by Product
• 8.3 Small molecules - Market size and forecast 2024-2029
  • Chart on Small molecules - Market size and forecast 2024-2029 ($ million)
  • Data Table on Small molecules - Market size and forecast 2024-2029 ($ million)
  • Chart on Small molecules - Year-over-year growth 2024-2029 (%)
  • Data Table on Small molecules - Year-over-year growth 2024-2029 (%)
• 8.4 Biologics - Market size and forecast 2024-2029
  • Chart on Biologics - Market size and forecast 2024-2029 ($ million)
  • Data Table on Biologics - Market size and forecast 2024-2029 ($ million)
  • Chart on Biologics - Year-over-year growth 2024-2029 (%)
  • Data Table on Biologics - Year-over-year growth 2024-2029 (%)
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)
  • Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Application

• 9.1 Market segments
  • Chart on Application - Market share 2024-2029 (%)
  • Data Table on Application - Market share 2024-2029 (%)
• 9.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
• 9.3 Hospital pharmacy - Market size and forecast 2024-2029
  • Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  • Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
• 9.4 Retail pharmacy - Market size and forecast 2024-2029
  • Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
  • Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
• 9.5 Online pharmacy - Market size and forecast 2024-2029
  • Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
  • Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
  • Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
• 9.6 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 9.7 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)

10 Market Segmentation by Therapy

• 10.1 Market segments
  • Chart on Therapy - Market share 2024-2029 (%)
  • Data Table on Therapy - Market share 2024-2029 (%)
• 10.2 Comparison by Therapy
  • Chart on Comparison by Therapy
  • Data Table on Comparison by Therapy
• 10.3 Chemotherapy - Market size and forecast 2024-2029
  • Chart on Chemotherapy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Chemotherapy - Market size and forecast 2024-2029 ($ million)
  • Chart on Chemotherapy - Year-over-year growth 2024-2029 (%)
  • Data Table on Chemotherapy - Year-over-year growth 2024-2029 (%)
• 10.4 Immunotherapy - Market size and forecast 2024-2029
  • Chart on Immunotherapy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Immunotherapy - Market size and forecast 2024-2029 ($ million)
  • Chart on Immunotherapy - Year-over-year growth 2024-2029 (%)
  • Data Table on Immunotherapy - Year-over-year growth 2024-2029 (%)
• 10.5 Combination therapies - Market size and forecast 2024-2029
  • Chart on Combination therapies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Combination therapies - Market size and forecast 2024-2029 ($ million)
  • Chart on Combination therapies - Year-over-year growth 2024-2029 (%)
  • Data Table on Combination therapies - Year-over-year growth 2024-2029 (%)
• 10.6 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 10.7 Market opportunity by Therapy
  • Market opportunity by Therapy ($ million)
  • Data Table on Market opportunity by Therapy ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 12.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 12.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 12.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 12.8 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 12.9 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 12.10 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 12.11 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 12.12 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 12.13 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 12.14 Mexico - Market size and forecast 2024-2029
  • Chart on Mexico - Market size and forecast 2024-2029 ($ million)
  • Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
  • Chart on Mexico - Year-over-year growth 2024-2029 (%)
  • Data Table on Mexico - Year-over-year growth 2024-2029 (%)
• 12.15 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
• 12.16 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 12.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

• 13.1 Market drivers
• 13.2 Market challenges
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities/restraints

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • SWOT
• 15.5 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key news
  • Amgen Inc. - Key offerings
  • SWOT
• 15.6 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
  • SWOT
• 15.7 BeiGene Ltd.
  • BeiGene Ltd. - Overview
  • BeiGene Ltd. - Business segments
  • BeiGene Ltd. - Key offerings
  • BeiGene Ltd. - Segment focus
  • SWOT
• 15.8 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings
  • SWOT
• 15.9 Celltrion Healthcare Co. Ltd.
  • Celltrion Healthcare Co. Ltd. - Overview
  • Celltrion Healthcare Co. Ltd. - Business segments
  • Celltrion Healthcare Co. Ltd. - Key offerings
  • Celltrion Healthcare Co. Ltd. - Segment focus
  • SWOT
• 15.10 Erytech Pharma SA
  • Erytech Pharma SA - Overview
  • Erytech Pharma SA - Product / Service
  • Erytech Pharma SA - Key offerings
  • SWOT
• 15.11 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.12 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
  • SWOT
• 15.13 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
  • SWOT
• 15.14 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
  • SWOT
• 15.15 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
  • SWOT
• 15.16 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 15.17 Spectrum Pharmaceuticals Inc.
  • Spectrum Pharmaceuticals Inc. - Overview
  • Spectrum Pharmaceuticals Inc. - Product / Service
  • Spectrum Pharmaceuticals Inc. - Key offerings
  • SWOT
• 15.18 Swedish Orphan Biovitrum AB
  • Swedish Orphan Biovitrum AB - Overview
  • Swedish Orphan Biovitrum AB - Product / Service
  • Swedish Orphan Biovitrum AB - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations